Last year, the Trump administration essentially disbanded the National Vaccine Program Office, folding it into an office focused on infectious diseases. Then the COVID-19 pandemic hit. What does this mean for monitoring the safety of the soon-to-be-approved COVID-19 vaccines?
Since the COVID-19 pandemic reached the US, increasing concern has been expressed about the politicization of the CDC and FDA due to pressure from the Trump administration to downplay the severity of the pandemic and push out treatments and a vaccine as fast as possible, potentially at the expense of safety. This has led me to a disturbing question: Can I trust the CDC and FDA any more?
Yesterday, the FDA issued emergency use authorization for hydroxychloroqine and chloroquine to treat COVID-19. Politics, not science, is why.
St. Elizabeth Healthcare in Cincinnati recently accepted $5 million from dōTERRA, an MLM company selling essential oils based on dubious claims. This is most definitely not a good look.
Federal “right-to-try” legislation was passed and signed into law by President Trump over a year ago. Advocates promised that lots of terminally ill people who were dying then would be saved by having the right to “try” experimental therapies outside of the context of clinical trials. That has not happened. This should come as no surprise, because right-to-try was never about getting experimental drugs to dying patients. It was always about weakening the FDA and making money.
